Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Leukemia, Lymphocytic, Chronic, B-Cell 9Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Unspecified Adult Solid Tumor, Protocol Specific 5Sezary Syndrome 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Mycosis Fungoides 5Lymphoma, T-Cell, Cutaneous 5Lymphoma, Non-Hodgkin 5Lymphoma, Large-Cell, Immunoblastic 5Burkitt Lymphoma 5Lymphoma, Large-Cell, Anaplastic 4Immunoblastic Lymphadenopathy 4Hodgkin Disease 4Waldenstrom Macroglobulinemia 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Accelerated Phase 3Leukemia 3Blast Crisis 3Sarcoma 2Prostatic Neoplasms 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Multiple Myeloma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Myeloid, Acute 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2

Interventions

Imatinib Mesylate 12Sunitinib 4Leucovorin 3ripretinib 2nilotinib 2avapritinib 2Oxaliplatin 2Irinotecan 2Ipilimumab 2Fluorouracil 2CTLA-4 Antigen 2umbralisib 1tanespimycin 1spartalizumab 1sargramostim 1ribociclib 1repaglinide 1regorafenib 1pexidartinib 1olverembatinib 1binimetinib 1alvocidib 1Thalidomide 1TH 302 1TAS-116 1Pharmacogenomic Testing 1OSI 930 1Midazolam 1IDRX-42 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Gastrointestinal Stromal Tumors × tanespimycin × Clear all
NCT00276302 2011-01-06

Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)

Infinity Pharmaceuticals, Inc.

Phase 1 Completed
63 enrolled
GastrointestinalSarcoma

Sarcoma, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡